PubMed · 9133194
Screening for HIV: ratios, risks and rationality.
Abstract
Screening patients or healthcare workers for Human Immunodeficiency Virus is unlikely to be cost-effective if the benefit is seen only as the prevention of infection of one group by the other within the healthcare institution. Overwhelmingly, the benefit of screening comes from interrupting the chains of infection within the ongoing epidemic in the population at large.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M E Jones. 1996. Screening for HIV: ratios, risks and rationality.. https://doi.org/10.1177/0310057x9602400211
Cite the original work for its findings. Save a collection to share your selection of sources.